Coronavirus, super-plagues, and why we need nuclear deterrence against biological warfare

Published



Imagine a super-plague resistant to antibiotics, or a smallpox variant resistant to vaccine.

That’s the contemporary bioweapons threat we must confront. The expanding COVID-19 epidemic has frayed a lot of nerves and caused the stock market to lose more than $1.5 trillion in the space of a few days. But that should not be our main concern. The minimal death rate for otherwise healthy individuals with the coronavirus means that we’ll get through this, likely without great suffering.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.